False-Positive Buprenorphine by CEDIA in Patients Prescribed Amisulpride or Sulpiride

M. A. Birch, L. Couchman*, S. Pietromartire, T. Karna, C. Paton, R. McAllister, A. Marsh, R. J. Flanagan

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    12 Citations (Scopus)

    Abstract

    Buprenorphine is a potent partial opioid agonist that is analyzed in urine to (i) monitor adherence to maintenance or detoxification therapy and (ii) detect illicit use. Buprenorphine analysis is commonly conducted on urine by immunoassay, but is subject to cross-reactivity from other drugs/drug metabolites, including morphine, codeine and dihydrocodeine. This study reports false-positive buprenorphine analysis [Thermo Fisher Scientific cloned enzyme donor immunoassay (CEDIA)] in patients who denied unauthorized buprenorphine use prior to sampling, but who had been prescribed amisulpride. In two cases, confirmatory analysis by liquid chromatographytandem mass spectrometry was negative (0.5 g/L) for buprenorphine and metabolites and positive for amisulpride. Although the cross-reactivity of amisulpride and sulpiride in the CEDIA buprenorphine assay is low (estimated at 0.003 and 0.002, respectively), it remains a significant consideration given the likely high concentrations of these compounds in urine relative to the low cutoff of the buprenorphine assay. Neither amisulpride nor sulpiride was listed as potential sources of interference on the CEDIA data sheet when this work was performed. These findings highlight the importance of confirming immunoassay-positive buprenorphine results using a more selective analytical technique.

    Original languageEnglish
    Pages (from-to)233-236
    Number of pages4
    JournalJournal of Analytical Toxicology
    Volume37
    Issue number4
    DOIs
    Publication statusPublished - May 2013

    Keywords

    • TANDEM MASS-SPECTROMETRY
    • HUMAN PLASMA
    • HUMAN URINE
    • NORBUPRENORPHINE
    • GLUCURONIDES
    • METHADONE

    Fingerprint

    Dive into the research topics of 'False-Positive Buprenorphine by CEDIA in Patients Prescribed Amisulpride or Sulpiride'. Together they form a unique fingerprint.

    Cite this